Zita Peach

Ms. Peach has more than 25 years of commercial experience in the pharmaceutical, biotechnology, medical devices, and health services industries.

She worked for major industry players such as CSL Limited and Merck Sharp &Dohme, the Australian subsidiary of Merck Inc.

Ms. Peach’s most recent executive position was as the Managing Director for Australia and New Zealand and Executive Vice President, South Asia Pacific for Fresenius Kabi, a leading provider of pharmaceutical products and medical devices to hospitals. Previously, Ms. Peach was Vice President, Business Development, for CSL Limited, a position she held for ten years.

Ms. Peach is a Non-Executive Director of the ASX-listed AirXpanders, Inc., Starpharma Holdings Limited, Pacific Smiles Group Limited, and Visioneering Technologies, Inc. Ms. Peach is also a member of the Hudson Institute of Medical Research Board.

Ms. Peach is a Fellow of the Australian Institute of Company Directors and a Fellow of the Australian Marketing Institute.